Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CELL THERAPEUTICS INC Key Ratios

  • Valuation Ratio: CTIC

    P/E (TTM) -0.02
    Price to CashFlow 0.26
    Price to Sales (TTM) 0.35
    Price to Book -15.02
  • Per Share Ratio: CTIC

    Dividend Per Share (TTM) 0.00
    Book Value Per Share -0.82
    EPS Fully Diluted -7.00
    Revenue Per Share 0.39
  • 5 Year Annual Growth: CTIC

    Net Income
    Revenue -14.32%
    Dividend Per Share (TTM) 0.00%
    EPS
  • Dividends: CTIC

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.00%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: CTIC

    Operations Margin -758.32%
    Net Profit Margin -1,574.78%
    Gross Profit Margin 25.89%
  • Financial Strength: CTIC

    Quick Ratio (MRQ) 0.61
    Current Ratio (MRQ) 0.49
    LT Debt to Equity (MRQ) -119.20
    Total Debt to Equity (MRQ) -121.91
    Return on Equity (ROE) Per Share -66.46
    Return on Assets (ROA) -116.87
    Return on Invested Capital (ROIC) -501.41
  • Assets: CTIC

    Asset Turnover 0.18
    Inventory Turnover 22.37